Stool Microbiome and Metabolome Differences between Colorectal Cancer Patients and Healthy Adults
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
In this study we used stool profiling to identify intestinal bacteria and metabolites that are differentially represented in humans with colorectal cancer (CRC) compared to healthy controls to identify how microbial functions may influence CRC development. Stool samples were collected from healthy adults (n = 10) and colorectal cancer patients (n = 11) prior to colon resection surgery at the University of Colorado Health-Poudre Valley Hospital in Fort Collins, CO. The V4 region of the 16s rRNA gene was pyrosequenced and both short chain fatty acids and global stool metabolites were extracted and analyzed utilizing Gas Chromatography-Mass Spectrometry (GC-MS). There were no significant differences in the overall microbial community structure associated with the disease state, but several bacterial genera, particularly butyrate-producing species, were under-represented in the CRC samples, while a mucin-degrading species, Akkermansia muciniphila, was about 4-fold higher in CRC (p<0.01). Proportionately higher amounts of butyrate were seen in stool of healthy individuals while relative concentrations of acetate were higher in stools of CRC patients. GC-MS profiling revealed higher concentrations of amino acids in stool samples from CRC patients and higher poly and monounsaturated fatty acids and ursodeoxycholic acid, a conjugated bile acid in stool samples from healthy adults (p<0.01). Correlative analysis between the combined datasets revealed some potential relationships between stool metabolites and certain bacterial species. These associations could provide insight into microbial functions occurring in a cancer environment and will help direct future mechanistic studies. Using integrated "omics" approaches may prove a useful tool in identifying functional groups of gastrointestinal bacteria and their associated metabolites as novel therapeutic and chemopreventive targets.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“a few cross-sectional studies reported that patients with CRC had a lower abundance of butyrate-producing species and lower fecal levels of butyrate than controls (Table 1).97, 133–135”
From Influence of the Gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer (2020) · cites this paper as [97]
In the citing paper
“Nevertheless, A. muciniphila has previously been linked to an increased burden of CRC in human and mice,25–27”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Naïve Bayesian Classifier for Rapid Assignment of rRNA Sequences into the New Bacterial Taxonomy
Wang, Q., Garrity, G. M., Tiedje, J. M., & Cole, J. R. (2007) · Applied and Environmental Microbiology · doi:10.1128/aem.00062-07 · Cited by 19,885
Schloss, P. D., Westcott, S. L., Ryabin, T., Hall, J. R., Hartmann, M., Hollister, E. B., Lesniewski, R. A., Oakley, B. B., Parks, D. H., Robinson, C. J., et al. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.01541-09 · Cited by 19,549
An obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444 · cited 2×
“A healthy gastrointestinal system relies on a balanced commensal biota to regulate processes such as dietary energy harvest [1], metabolism of microbial and host derived chemicals [2], and immune modulation [3].”
BackgroundDe Filippo, C., Cavalieri, D., Di Paola, M., Ramazzotti, M., Poullet, J. B., Massart, S., Collini, S., Pieraccini, G., & Lionetti, P. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1005963107 · Cited by 5,579 · cited 2×
“Prevotella was a dominant genera reported in stool from children in a rural community in Burkina Faso but absent from a cohort of Italian children, and the study authors hypothesized that Prevotella helped maximize energy harvest from a plant-based diet [29].”
BackgroundSmith, C. A., Want, E. J., O'Maille, G., Abagyan, R., & Siuzdak, G. (2006) · Analytical Chemistry · doi:10.1021/ac051437y · Cited by 5,262
Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma
Castellarin, M., Warren, R. L., Freeman, J. D., Dreolini, L., Krzywinski, M., Strauss, J., Barnes, R., Watson, P., Allen-Vercoe, E., Moore, R. A., et al. (2012) · Genome Research · doi:10.1101/gr.126516.111 · Cited by 2,043
Genomic analysis identifies association of Fusobacterium with colorectal carcinoma
Kostic, A. D., Gevers, D., Pedamallu, C. S., Michaud, M., Duke, F., Earl, A. M., Ojesina, A. I., Jung, J., Bass, A. J., Tabernero, J., et al. (2012) · Genome Research · doi:10.1101/gr.126573.111 · Cited by 1,960
Nicholson, J. K., & Lindon, J. C. (2008) · Nature · doi:10.1038/4551054a · Cited by 1,886
Microbes in Gastrointestinal Health and Disease
Neish, A. S. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.10.080 · Cited by 1,386
Png, C. W., Lindén, S. K., Gilshenan, K. S., Zoetendal, E. G., McSweeney, C. S., Sly, L. I., McGuckin, M. A., & Florin, T. H. J. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.281 · Cited by 1,364 · cited 2×
“This bacterium is a common member of the colonic microbiota and was recently shown to be reduced in irritable bowel syndrome and Crohn’s Disease [32]; however a more recent report showed increased A. muciniphila in ulcerative colitis-associated pouchitis [33].”
Background
Research works printed but not linked: 1
- J Byrd, 2004, Mucins and mucin binding proteins in colorectal cancer, Cancer and Metastasis Reviews, 23, 77, 10.1023/A:1025815113599 · DOI · Paper page
Cited by
Kelly, C. J., Zheng, L., Campbell, E. L., Saeedi, B., Scholz, C. C., Bayless, A. J., Wilson, K. E., Glover, L. E., Kominsky, D. J., Magnuson, A., et al. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.03.005 · Cited by 1,716
“SCFA quantification was performed with gas chromatographymass spectrometry (GC-MS) following extraction of SCFAs from cecal contents in acidified water as described elsewhere (Weir et al., 2013).”
Self-citationGut microbiome development along the colorectal adenoma-carcinoma sequence
Feng, Q., Liang, S., Jia, H., Stadlmayr, A., Tang, L., Lan, Z., Zhang, D., Xia, H., Xu, X., Jie, Z., et al. (2015) · Nature Communications · doi:10.1038/ncomms7528 · Cited by 1,506
Wirbel, J., Pyl, P. T., Kartal, E., Zych, K., Kashani, A., Milanese, A., Fleck, J. S., Voigt, A. Y., Palleja, A., Ponnudurai, R., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0406-6 · Cited by 1,373
Potential of fecal microbiota for early-stage detection of colorectal cancer
Zeller, G., Tap, J., Voigt, A. Y., Sunagawa, S., Kultima, J. R., Costea, P. I., Amiot, A., Böhm, J., Brunetti, F., Habermann, N., et al. (2014) · Molecular Systems Biology · doi:10.15252/msb.20145645 · Cited by 1,375
“Boxplots are as defined in Fig 1E. Molecular Systems Biology 10: 766 | 2014 ª 2014 The Authors Some host cell-derived metabolites are more abundant in the tumor environment, for instance amino acids, of which elevated levels have been measured in CRC patients by metabolomics (Weir et al, 2013).”
Gut microbiota in colorectal cancer: mechanisms of action and clinical applications
Wong, S. H., & Yu, J. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0209-8 · Cited by 1,331
Impacts of gut bacteria on human health and diseases
Zhang, Y.-J., Li, S., Gan, R.-Y., Zhou, T., Xu, D.-P., & Li, H.-B. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16047493 · Cited by 1,055
“On the other hand, Acidaminobacter, Phascolarctobacterium, Citrobacter farmer, and Akkermansia muciniphila significantly over-represented in colorectal cancer (CRC) stool samples [104].”
BackgroundGut microbiota-derived bile acids in intestinal immunity, inflammation, and tumorigenesis
Cai, J., Sun, L., & Gonzalez, F. J. (2022) · Cell Host & Microbe · doi:10.1016/j.chom.2022.02.004 · Cited by 843
Influence of the Gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer
Song, M., Chan, A. T., & Sun, J. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.06.048 · Cited by 752
He, Y., Fu, L., Li, Y., Wang, W., Gong, M., Zhang, J., Dong, X., Huang, J., Wang, Q., Mackay, C. R., et al. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.03.002 · Cited by 729
Sequencing and beyond: integrating molecular 'omics' for microbial community profiling
Franzosa, E. A., Hsu, T., Sirota-Madi, A., Shafquat, A., Abu-Ali, G., Morgan, X. C., & Huttenhower, C. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3451 · Cited by 719
Akkermansia muciniphila is a promising probiotic
Zhang, T., Li, Q., Cheng, L., Buch, H., & Zhang, F. (2019) · Microbial Biotechnology · doi:10.1111/1751-7915.13410 · Cited by 708
“However, Weir et al. (2013) found that the level of A. muciniphila was obviously elevated in patients with colorectal cancer compared with that in healthy individuals.”
BackgroundWang, L., Tang, L., Feng, Y., Zhao, S., Han, M., Zhang, C., Yuan, G., Zhu, J., Cao, S., Wu, Q., et al. (2020) · Gut · doi:10.1136/gutjnl-2019-320105 · Cited by 630
The Microbiota of Breast Tissue and Its Association with Breast Cancer
Urbaniak, C., Gloor, G. B., Brackstone, M., Scott, L., Tangney, M., & Reid, G. (2016) · Applied and Environmental Microbiology · doi:10.1128/aem.01235-16 · Cited by 625
“In colorectal cancer (CRC) and oral squamous cell carcinoma (OSCC), bacterial profiles in the stool and saliva, respectively, also differ between healthy and diseased patients (30–32), with evidence suggesting that changes in this community composition and function may be driving cancer progression at these sites (33,…”
BackgroundDai, Z., Coker, O. O., Nakatsu, G., Wu, W. K. K., Zhao, L., Chen, Z., Chan, F. K. L., Kristiansen, K., Sung, J. J. Y., Wong, S. H., et al. (2018) · Microbiome · doi:10.1186/s40168-018-0451-2 · Cited by 545
“Prevotella was found to be enriched in proximal colon cancer [5], despite the controversial results reported in another study [33].”
Aguiar-Pulido, V., Huang, W., Suarez-Ulloa, V., Cickovski, T., Mathee, K., & Narasimhan, G. (2016) · Evolutionary Bioinformatics · doi:10.4137/ebo.s36436 · Cited by 499
Donohoe, D. R., Holley, D., Collins, L. B., Montgomery, S. A., Whitmore, A. C., Hillhouse, A., Curry, K. P., Renner, S. W., Greenwalt, A., Ryan, E. P., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0501 · Cited by 474
“colorectal cancer cases than controls even without diet being taken into consideration (32-36).”
BackgroundAltered Gut Microbiota in a Mouse Model of Alzheimer’s Disease
Zhang, L., Wang, Y., Xiayu, X., Shi, C., Chen, W., Song, N., Fu, X., Zhou, R., Xu, Y.-F., Huang, L., et al. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170020 · Cited by 449
“Concentrations of A. muciniphila were also significantly increased in fecal samples from colon cancer patients [55].”
Metagenome-wide association studies: fine-mining the microbiome
Wang, J., & Jia, H. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.83 · Cited by 429
Disentangling metabolic functions of bacteria in the honey bee gut
Kešnerová, L., Mars, R. A. T., Ellegaard, K. M., Troilo, M., Sauer, U., & Engel, P. (2017) · PLOS Biology · doi:10.1371/journal.pbio.2003467 · Cited by 408
Colorectal Cancer and the Human Gut Microbiome: Reproducibility with Whole-Genome Shotgun Sequencing
Vogtmann, E., Hua, X., Zeller, G., Sunagawa, S., Voigt, A. Y., Hercog, R., Goedert, J. J., Shi, J., Bork, P., & Sinha, R. (2016) · PLOS ONE · doi:10.1371/journal.pone.0155362 · Cited by 366
“Of the previous microbiome and CRC studies, some used 16S rRNA gene sequencing [2, 4, 5, 7, 9], while others used whole-genome shotgun sequencing/shotgun metagenomics (WGSS; [3, 6, 8]).”
MethodResultPoyet, M., Groussin, M., Gibbons, S. M., Avila-Pacheco, J., Jiang, X., Kearney, S. M., Perrotta, A. R., Berdy, B., Zhao, S., Lieberman, T. D., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0559-3 · Cited by 376
Hibberd, A. A., Lyra, A., Ouwehand, A. C., Rolny, P., Lindegren, H., Cedgård, L., & Wettergren, Y. (2017) · BMJ Open Gastroenterology · doi:10.1136/bmjgast-2017-000145 · Cited by 373
Drewes, J. L., White, J. R., Dejea, C. M., Fathi, P., Iyadorai, T., Vadivelu, J., Roslani, A. C., Wick, E. C., Mongodin, E. F., Loke, M. F., et al. (2017) · npj Biofilms and Microbiomes · doi:10.1038/s41522-017-0040-3 · Cited by 335
“Importantly, the enrichment of B. fragilis was paralleled by depletion of several other Bacteroides members, which is consistent with reports by others of an overall loss of phylum Bacteroidetes3 and more specifically the genus Bacteroides.9,12 The selective enrichment of B. fragilis may therefore suggest a growth adv…”
ResultMicrobiome and colorectal cancer: Roles in carcinogenesis and clinical potential
Saus, E., Iraola-Guzmán, S., Willis, J. R., Brunet-Vega, A., & Gabaldón, T. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2019.05.001 · Cited by 350
“Between the highly conserved regions of this 16S gene, there are nine highly variable regions (named V1 through V9), so mapping the read sequences to a database of known 16S rRNA gene sequences allows for taxonomic identification of the bacteria present in a sample (Weisburg et al., 1991).”
Backgroundvan der Beek, C. M., Dejong, C. H. C., Troost, F. J., Masclee, A. A. M., & Lenaerts, K. (2017) · Nutrition Reviews · doi:10.1093/nutrit/nuw067 · Cited by 343
Nho, K., Kueider‐Paisley, A., MahmoudianDehkordi, S., Arnold, M., Risacher, S. L., Louie, G., Blach, C., Baillie, R., Han, X., Kastenmüller, G., et al. (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.08.012 · Cited by 343
“Existing studies elucidating relations between gut microbial metabolism and the human me-tabolome have mainly used statistical analyses to correlate individual compounds with microbial taxa [89,90].”
Integration of GC–MS and LC–MS for untargeted metabolomics profiling
Zeki, Ö. C., Eylem, C. C., Reçber, T., Kır, S., & Nemutlu, E. (2020) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2020.113509 · Cited by 336
Taurocholic acid metabolism by gut microbes and colon cancer
Ridlon, J. M., Wolf, P. G., & Gaskins, H. R. (2016) · Gut Microbes · doi:10.1080/19490976.2016.1150414 · Cited by 327
Gastrointestinal Malignancy and the Microbiome
Abreu, M. T., & Peek, R. M. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.01.001 · Cited by 322
“changes in the microbiome of cancer tissues are related to changes in the availability of nutrients and other conditions created by the cancer cells themselves.(84,91) Studies of the composition of the stool may someday be helpful, especially if paired with polymerase chain reaction–based studies of host DNA mutations…”
BackgroundGuerrero-Preston, R., Godoy-Vitorino, F., Jedlicka, A., Rodríguez-Hilario, A., González, H., Bondy, J., Lawson, F., Folawiyo, O., Michailidi, C., Dziedzic, A., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9710 · Cited by 313
Influences of diet and the gut microbiome on epigenetic modulation in cancer and other diseases
Paul, B., Barnes, S., Demark-Wahnefried, W., Morrow, C., Salvador, C., Skibola, C., & Tollefsbol, T. O. (2015) · Clinical Epigenetics · doi:10.1186/s13148-015-0144-7 · Cited by 306
“A study of the stool microbiome and metabolome differences between colorectal cancer (CRC) and healthy adults showed that several butyrate-producing bacteria were underrepresented in CRC samples, whereas mucindegrading species Akkermansia muciniphila were about fourfold higher [95].”
BackgroundCancer-promoting effects of microbial dysbiosis
Sheflin, A. M., Whitney, A. K., & Weir, T. L. (2014) · Current Oncology Reports · doi:10.1007/s11912-014-0406-0 · Cited by 301
Self-citationInterindividual variability in gut microbiota and host response to dietary interventions
Healey, G. R., Murphy, R., Brough, L., Butts, C. A., & Coad, J. (2017) · Nutrition Reviews · doi:10.1093/nutrit/nux062 · Cited by 292
“Butyrate-producing species have been shown to be under-represented in patients with colorectal cancer.(74) Ohigashi and colleagues(6) established that colorectal cancer patients (n1⁄4 93) also had lower total bacteria, C.”
Yang, Y., Misra, B. B., Liang, L., Bi, D., Weng, W., Wu, W., Cai, S., Qin, H., Goel, A., Li, X., et al. (2019) · Theranostics · doi:10.7150/thno.35186 · Cited by 294
“Previous studies have also documented increases in the amino acids Pro and Glu and decreases in glycerol, linoleic, and oleic acids in CRC patients [22, 23].”
ResultA review of metabolic potential of human gut microbiome in human nutrition
Yadav, M., Verma, M. K., & Chauhan, N. S. (2018) · Archives of Microbiology · doi:10.1007/s00203-017-1459-x · Cited by 290
Chen, F., Dai, X., Zhou, C.-C., Li, K.-X., Zhang, Y.-J., Lou, X.-Y., Zhu, Y.-M., Sun, Y.-L., Peng, B.-X., & Cui, W. (2022) · Gut · doi:10.1136/gutjnl-2020-323476 · Cited by 283
Manipulating the gut microbiota to maintain health and treat disease
Scott, K. P., Antoine, J.-M., Midtvedt, T., & van Hemert, S. (2015) · Microbial Ecology in Health & Disease · doi:10.3402/mehd.v26.25877 · Cited by 281
“muciniphila were four times higher in patients with colorectal cancer than in healthy controls (33).”
BackgroundBoursi, B., Mamtani, R., Haynes, K., & Yang, Y.-X. (2015) · European Journal of Cancer · doi:10.1016/j.ejca.2015.08.015 · Cited by 263
“Numerous mechanisms have been proposed to explain the association between bacterial dysbiosis and cancer risk, including induction of chronic inflammation; changes in the normal tissue metabolism; direct genotoxic effects; and weakening of the immune response [5,9–13].”
BackgroundMira-Pascual, L., Cabrera-Rubio, R., Ocon, S., Costales, P., Parra, A., Suarez, A., Moris, F., Rodrigo, L., Mira, A., & Collado, M. C. (2015) · Journal of Gastroenterology · doi:10.1007/s00535-014-0963-x · Cited by 262
A review on human fecal metabolomics: Methods, applications and the human fecal metabolome database
Karu, N., Deng, L., Slae, M., Guo, A. C., Sajed, T., Huynh, H., Wine, E., & Wishart, D. S. (2018) · Analytica Chimica Acta · doi:10.1016/j.aca.2018.05.031 · Cited by 261
Gut microbiota, inflammation and colorectal cancer
Sun, J., & Kato, I. (2016) · Genes & Diseases · doi:10.1016/j.gendis.2016.03.004 · Cited by 257
“Others did not find differences in these alpha diversity indices.(9,10,15,16) With or without using additional quantitative PCR (qPCR), these studies have also found that specific bacterial groups were more common or less common in colorectal cancer cases than control specimens.”
BackgroundCoker, O. O., Liu, C., Wu, W. K. K., Wong, S. H., Jia, W., Sung, J. J. Y., & Yu, J. (2022) · Microbiome · doi:10.1186/s40168-021-01208-5 · Cited by 255
Brown, D. G., Rao, S., Weir, T. L., O’Malia, J., Bazan, M., Brown, R. J., & Ryan, E. P. (2016) · Cancer & Metabolism · doi:10.1186/s40170-016-0151-y · Cited by 254
Microbiome in Colorectal Cancer: How to Get from Meta-omics to Mechanism?
Ternes, D., Karta, J., Tsenkova, M., Wilmes, P., Haan, S., & Letellier, E. (2020) · Trends in Microbiology · doi:10.1016/j.tim.2020.01.001 · Cited by 251
Locoregional Effects of Microbiota in a Preclinical Model of Colon Carcinogenesis
Tomkovich, S., Yang, Y., Winglee, K., Gauthier, J., Mühlbauer, M., Sun, X., Mohamadzadeh, M., Liu, X., Martin, P., Wang, G. P., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-3472 · Cited by 252
Emerging roles of the microbiome in cancer
Bultman, S. J. (2014) · Carcinogenesis · doi:10.1093/carcin/bgt392 · Cited by 239
Mancabelli, L., Milani, C., Lugli, G. A., Turroni, F., Cocconi, D., van Sinderen, D., & Ventura, M. (2017) · FEMS Microbiology Ecology · doi:10.1093/femsec/fix153 · Cited by 238
“In detail, we collected 359, 1457; 512 and 720 samples belonging to CRC (Kostic et al. 2012; Geng et al. 2013; Weir et al. 2013; Wu et al. 2013; Zackular et al. 2014; Burns et al. 2015), CD (Gevers et al.”
BackgroundZhang, Q., Wu, Y., Wang, J., Wu, G., Long, W., Xue, Z., Wang, L., Zhang, X., Pang, X., Zhao, Y., et al. (2016) · Scientific Reports · doi:10.1038/srep27572 · Cited by 233
Virulence genes are a signature of the microbiome in the colorectal tumor microenvironment
Burns, M. B., Lynch, J., Starr, T. K., Knights, D., & Blekhman, R. (2015) · Genome Medicine · doi:10.1186/s13073-015-0177-8 · Cited by 231
“CRC patients were found to have higher levels of some amino acids and alterations in the levels of some short chain fatty acids (SCFAs) in their stools when compared with controls [25].”
The gut microbiota in conventional and serrated precursors of colorectal cancer
Peters, B. A., Dominianni, C., Shapiro, J. A., Church, T. R., Wu, J., Miller, G., Yuen, E., Freiman, H., Lustbader, I., Salik, J., et al. (2016) · Microbiome · doi:10.1186/s40168-016-0218-6 · Cited by 230
“Other studies have also found decreased relative abundance of butyrate-producing bacteria in adenoma [33, 47, 48] and CRC [36, 37], supporting the protective effects of butyrate against CRC.”
BackgroundComparative In silico Analysis of Butyrate Production Pathways in Gut Commensals and Pathogens
Anand, S., Kaur, H., & Mande, S. S. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01945 · Cited by 222
Combined Signature of the Fecal Microbiome and Metabolome in Patients with Gout
Shao, T., Shao, L., Li, H., Xie, Z., He, Z., & Wen, C. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00268 · Cited by 215
(2020) · Progress in Molecular Biology and Translational Science · doi:10.1016/bs.pmbts.2020.04.003 · Cited by 212
Epidemiologic studies of the human microbiome and cancer
Vogtmann, E., & Goedert, J. J. (2016) · British Journal of Cancer · doi:10.1038/bjc.2015.465 · Cited by 211
Noecker, C., Eng, A., Srinivasan, S., Theriot, C. M., Young, V. B., Jansson, J. K., Fredricks, D. N., & Borenstein, E. (2016) · mSystems · doi:10.1128/msystems.00013-15 · Cited by 210
Lopez-Siles, M., Enrich-Capó, N., Aldeguer, X., Sabat-Mir, M., Duncan, S. H., Garcia-Gil, L. J., & Martinez-Medina, M. (2018) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2018.00281 · Cited by 209
“muciniphila abundance in CRC patients compared to controls has been previously found in stools (Weir et al., 2013) but not in mucosal biopsies (Mira-Pascual et al.”
BackgroundReview of the mechanisms of probiotic actions in the prevention of colorectal cancer
dos Reis, S. A., da Conceição, L. L., Siqueira, N. P., Rosa, D. D., da Silva, L. L., & Peluzio, M. D. C. G. (2017) · Nutrition Research · doi:10.1016/j.nutres.2016.11.009 · Cited by 209
The gastrointestinal microbiota and colorectal cancer
Keku, T. O., Dulal, S., Deveaux, A., Jovov, B., & Han, X. (2015) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00360.2012 · Cited by 205
“Weir et al. 2013 (166b) Feces CRC Decreased butyrate-producing bacteria in CRC. Wu et al. 2013 (171) Feces CRC Bacterial dysbiosis, altered diversity, enriched Bacteroides, overabundance of Fusobacterium and Campylobacter, and decreased butyrate-producing bacteria in CRC cases compared with healthy…”
Diet, the Gut Microbiome, and Epigenetics
Hullar, M. A. J., & Fu, B. C. (2014) · The Cancer Journal · doi:10.1097/ppo.0000000000000053 · Cited by 203
“A study of the microbiome in colorectal and healthy subjects found a 63% increase in the amount of UDCA in stools of healthy individuals correlated with Ruminococcus species.(102) Secondary bile acids, deoxycholate (DCA), lithodeoxycholate (LDA), and UDCA, increase in response to high-fat diets and are increased in po…”
BackgroundThe Impact of Environmental Chemicals on the Gut Microbiome
Chiu, K., Warner, G., Nowak, R. A., Flaws, J. A., & Mei, W. (2020) · Toxicological Sciences · doi:10.1093/toxsci/kfaa065 · Cited by 198
“This is of concern because Akkermansia, which plays a role in butyrate production, is also elevated in human cancers (Baxter et al., 2014; Weir et al., 2013), implying that BPA-induced gut microbiome alterations may increase the risk of carcinogenesis.”
BackgroundShifts in the Fecal Microbiota Associated with Adenomatous Polyps
Hale, V. L., Chen, J., Johnson, S., Harrington, S. C., Yab, T. C., Smyrk, T. C., Nelson, H., Boardman, L. A., Druliner, B. R., Levin, T. R., et al. (2017) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-16-0337 · Cited by 199
“Because the gut microbiota alters the metabolic environment of the host, it may directly or indirectly in fl uence mutagenesis rates (11, 17), and thus carcinogenesis.”
BackgroundHanus, M., Parada-Venegas, D., Landskron, G., Wielandt, A. M., Hurtado, C., Alvarez, K., Hermoso, M. A., López-Köstner, F., & De la Fuente, M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.612826 · Cited by 199
Role of SCFAs in gut microbiome and glycolysis for colorectal cancer therapy
Wang, G., Yu, Y., Wang, Y., Wang, J., Guan, R., Sun, Y., Shi, F., Gao, J., & Fu, X. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28436 · Cited by 199
“…as Dysgonomonas spp., Campylobacter spp., and Mycoplasma spp.) were downregulated with Rb3/Rd treatments (Cummins, Joanne, Tangney, & Mark, 2013; Weir et al., 2013), it has also been observed that Akkermansia muciniphila and some of the Blautia species (e.g., Blautia coccoides, Blautia…”
BackgroundClos-Garcia, M., Andrés-Marin, N., Fernández-Eulate, G., Abecia, L., Lavín, J. L., van Liempd, S., Cabrera, D., Royo, F., Valero, A., Errazquin, N., et al. (2019) · eBioMedicine · doi:10.1016/j.ebiom.2019.07.031 · Cited by 198
“Metabolomics-microbiome integration studies using correlation approaches have shown the effect of microbiome on host's insulin sensitivity [70] and on the development and progression of colorectal cancer [66,100].”
BackgroundRole of colonic microbiota in colorectal carcinogenesis: A systematic review
Borges Canha, M. (2015) · Revista Española de Enfermedades Digestivas · doi:10.17235/reed.2015.3830/2015 · Cited by 193
Brodmann, T., Endo, A., Gueimonde, M., Vinderola, G., Kneifel, W., de Vos, W. M., Salminen, S., & Gómez-Gallego, C. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01725 · Cited by 191
“Colorectal cancer patients showed a four-fold increase of A. muciniphila in stool samples compared to healthy subjects (Weir et al., 2013).”
BackgroundKaźmierczak-Siedlecka, K., Daca, A., Fic, M., van de Wetering, T., Folwarski, M., & Makarewicz, W. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1764309 · Cited by 191
“and Pseudobutyrivibrio ruminis, were lower in stool samples from CRC patients in comparison to healthy controls.(32) Similarly, another study showed that colorectal cancer patients’ stool samples were depleted of butyrate and several butyrateproducing bacteria.”
ResultFecal Transplants: What Is Being Transferred?
Bojanova, D. P., & Bordenstein, S. R. (2016) · PLOS Biology · doi:10.1371/journal.pbio.1002503 · Cited by 190
Mancabelli, L., Milani, C., Lugli, G. A., Turroni, F., Mangifesta, M., Viappiani, A., Ticinesi, A., Nouvenne, A., Meschi, T., van Sinderen, D., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-10663-w · Cited by 182
Shah, M. S., DeSantis, T. Z., Weinmaier, T., McMurdie, P. J., Cope, J. L., Altrichter, A., Yamal, J.-M., & Hollister, E. B. (2018) · Gut · doi:10.1136/gutjnl-2016-313189 · Cited by 180
Kim, M., Vogtmann, E., Ahlquist, D. A., Devens, M. E., Kisiel, J. B., Taylor, W. R., White, B. A., Hale, V. L., Sung, J., Chia, N., et al. (2020) · mBio · doi:10.1128/mbio.03186-19 · Cited by 179
“So far, in the context of CRC research, there have been only a few studies which globally profiled both gut microbiome and metabolome simultaneously (25–27).”
Guo, X., Li, S., Zhang, J., Wu, F., Li, X., Wu, D., Zhang, M., Ou, Z., Jie, Z., Yan, Q., et al. (2017) · BMC Genomics · doi:10.1186/s12864-017-4195-3 · Cited by 176
“muciniphila was enriched in type 2 diabetes [22] and colorectal cancer subjects [23].”
BackgroundLamas, B., Martins Breyner, N., & Houdeau, E. (2020) · Particle and Fibre Toxicology · doi:10.1186/s12989-020-00349-z · Cited by 174
“Bacteroides (g) ↙[183, 194] ↙[17, 186, 197, 201] ↗[202, 203] ↙Ag, TiO2, SiO2 [107, 108]; ↗Ag, ZnO [105, 110]”
Ocvirk, S., & O’Keefe, S. J. (2017) · Current Nutrition Reports · doi:10.1007/s13668-017-0219-5 · Cited by 173
Parkinson’s Disease and the Gastrointestinal Microbiome
Lubomski, M., Tan, A. H., Lim, S.-Y., Holmes, A. J., Davis, R. L., & Sue, C. M. (2020) · Journal of Neurology · doi:10.1007/s00415-019-09320-1 · Cited by 172
“Furthermore, lowered Prevotella abundance is not entirely specific to PD, as other conditions including type I diabetes [157], colon cancer [158] and autism [159], also share reduced Prevotella abundances.”
BackgroundKirwan, J. A., Brennan, L., Broadhurst, D., Fiehn, O., Cascante, M., Dunn, W. B., Schmidt, M. A., & Velagapudi, V. (2018) · Clinical Chemistry · doi:10.1373/clinchem.2018.287045 · Cited by 170
Wilson, A. (2018) · Sensors · doi:10.3390/s18082613 · Cited by 171
Corb Aron, R. A., Abid, A., Vesa, C. M., Nechifor, A. C., Behl, T., Ghitea, T. C., Munteanu, M. A., Fratila, O., Andronie-Cioara, F. L., Toma, M. M., et al. (2021) · Microorganisms · doi:10.3390/microorganisms9030618 · Cited by 169
Recent findings in Akkermansia muciniphila-regulated metabolism and its role in intestinal diseases
Liu, M.-J., Yang, J.-Y., Yan, Z.-H., Hu, S., Li, J.-Q., Xu, Z.-X., & Jian, Y.-P. (2022) · Clinical Nutrition · doi:10.1016/j.clnu.2022.08.029 · Cited by 166
Metabonomics of Human Colorectal Cancer: New Approaches for Early Diagnosis and Biomarker Discovery
Ni, Y., Xie, G., & Jia, W. (2014) · Journal of Proteome Research · doi:10.1021/pr500443c · Cited by 165
Analysis of short-chain fatty acids in human feces: A scoping review
Primec, M., Mičetić-Turk, D., & Langerholc, T. (2017) · Analytical Biochemistry · doi:10.1016/j.ab.2017.03.007 · Cited by 165
Javurek, A. B., Spollen, W. G., Johnson, S. A., Bivens, N. J., Bromert, K. H., Givan, S. A., & Rosenfeld, C. S. (2016) · Gut Microbes · doi:10.1080/19490976.2016.1234657 · Cited by 160
Comparison of Collection Methods for Fecal Samples in Microbiome Studies
Vogtmann, E., Chen, J., Amir, A., Shi, J., Abnet, C. C., Nelson, H., Knight, R., Chia, N., & Sinha, R. (2017) · American Journal of Epidemiology · doi:10.1093/aje/kww177 · Cited by 161
Culture independent assessment of human milk microbial community in lactational mastitis
Patel, S. H., Vaidya, Y. H., Patel, R. J., Pandit, R. J., Joshi, C. G., & Kunjadiya, A. P. (2017) · Scientific Reports · doi:10.1038/s41598-017-08451-7 · Cited by 163
Saffarian, A., Mulet, C., Regnault, B., Amiot, A., Tran-Van-Nhieu, J., Ravel, J., Sobhani, I., Sansonetti, P. J., & Pédron, T. (2019) · mBio · doi:10.1128/mbio.01315-19 · Cited by 164
Cancer metabolomic markers in urine: evidence, techniques and recommendations
Dinges, S. S., Hohm, A., Vandergrift, L. A., Nowak, J., Habbel, P., Kaltashov, I. A., & Cheng, L. L. (2019) · Nature Reviews Urology · doi:10.1038/s41585-019-0185-3 · Cited by 161
Gut Microbiota in Colorectal Cancer: Biological Role and Therapeutic Opportunities
Pandey, H., Tang, D. W. T., Wong, S. H., & Lal, D. (2023) · Cancers · doi:10.3390/cancers15030866 · Cited by 159
The curious case of Prevotella copri
Abdelsalam, N. A., Hegazy, S. M., & Aziz, R. K. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2249152 · Cited by 160
“copri was reportedly more abundant in the fecal microbiomes of healthy individuals than those of patients with colorectal cancer.(83,84) In a study combining wet-lab investigation and meta-analysis of fecal microbiome data of patients with melanoma, P.”
BackgroundFiebiger, U., Bereswill, S., & Heimesaat, M. M. (2016) · European Journal of Microbiology and Immunology · doi:10.1556/1886.2016.00036 · Cited by 159
“aminobacter, Phascolarctobacterium, Citrobacter farmeri and Akkermansia mucinophila abundances were increased [83].”
BackgroundMontassier, E., Batard, E., Massart, S., Gastinne, T., Carton, T., Caillon, J., Le Fresne, S., Caroff, N., Hardouin, J. B., Moreau, P., et al. (2014) · Microbial Ecology · doi:10.1007/s00248-013-0355-4 · Cited by 158
“Nevertheless, the cost of this option can be prohibitive, and alternatives have been proposed like performing PCR in replicates before pooling the PCR amplicons [46].”
BackgroundRojo, D., Méndez-García, C., Raczkowska, B. A., Bargiela, R., Moya, A., Ferrer, M., & Barbas, C. (2017) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuw046 · Cited by 157
“For example, an association with colorectal cancer was found for 78 faecal metabolites (Monleón et al. 2009; Ou et al. 2013; Weir et al. 2013; Goedert et al. 2014; Bjerrum et al. 2015; Wang et al. 2015; Sinha et al. 2016), 36 are associated with gastrointestinal disease cryptosporidiosis (Ng et al.”
BackgroundInfluentialThe Gut Microbiome Signatures Discriminate Healthy From Pulmonary Tuberculosis Patients
Hu, Y., Feng, Y., Wu, J., Liu, F., Zhang, Z., Hao, Y., Liang, S., Li, B., Li, J., Lv, N., et al. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00090 · Cited by 154
“, 2014), colorectal cancer (Weir et al., 2013), and T2D (Qin et al.”
BackgroundFecal metabolomics: assay performance and association with colorectal cancer
Goedert, J. J., Sampson, J. N., Moore, S. C., Xiao, Q., Xiong, X., Hayes, R. B., Ahn, J., Shi, J., & Sinha, R. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu131 · Cited by 163
The Role of Gut Barrier Dysfunction and Microbiome Dysbiosis in Colorectal Cancer Development
Genua, F., Raghunathan, V., Jenab, M., Gallagher, W. M., & Hughes, D. J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.626349 · Cited by 172
“and Pseudobutyrivibrio ruminis, were found to be lower in stool samples from CRC patients in comparison to controls (106).”
ResultChen, Y., Fang, L., Chen, S., Zhou, H., Fan, Y., Lin, L., Li, J., Xu, J., Chen, Y., Ma, Y., et al. (2020) · BioMed Research International · doi:10.1155/2020/8456596 · Cited by 146
Ralser, A., Dietl, A., Jarosch, S., Engelsberger, V., Wanisch, A., Janssen, K., Middelhoff, M. A., Vieth, M. W., Quante, M., Haller, D., et al. (2023) · Gut · doi:10.1136/gutjnl-2022-328075 · Cited by 171
van Keulen, K. E., Jansen, M. E., Schrauwen, R. W. M., Kolkman, J. J., & Siersema, P. D. (2019) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15622 · Cited by 142
Hsu, Y.-L., Chen, C., Lin, Y., Wu, W., Chang, L., Lai, C.-H., Wu, M., & Kuo, C. (2019) · Journal of Proteome Research · doi:10.1021/acs.jproteome.8b00536 · Cited by 151
Intestinal microbiota and its association with colon cancer and red/processed meat consumption
Abu‐Ghazaleh, N., Chua, W. J., & Gopalan, V. (2020) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15042 · Cited by 169
Evaluation and comparison of short chain fatty acids composition in gut diseases
Niccolai, E., Baldi, S., Ricci, F., Russo, E., Nannini, G., Menicatti, M., Poli, G., Taddei, A., Bartolucci, G., Calabrò, A. S., et al. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i36.5543 · Cited by 139
Metadata
- Authors
- Weir, T. L., Manter, D. K., Sheflin, A. M., Barnett, B. A., Heuberger, A. L., & Ryan, E. P.
- Affiliations
- Colorado State University (US)
- Agricultural Research Service (US)
- Corresponding author
- Weir, Tiffany L.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-08-06
- Volume
- 8
- Issue
- 8
- Pages
- e70803
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3735522
- OpenAlex
- W2115450300
- Cited by
- 642
- References
- 48
- Citations by year
- 2026: 15 · 2025: 40 · 2024: 37 · 2023: 60 · 2022: 66 · 2021: 67 · 2020: 67 · 2019: 74 · 2018: 58 · 2017: 53 · 2016: 54 · 2015: 29 · 2014: 21 · 2013: 1
- FWCI
- 15.69
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- National Institutes of Health
- National Cancer Institute (R03CA150070)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolomics and Mass Spectrometry Studies
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Keywords
- colorectal cancer, gut microbiota, Akkermansia muciniphila, butyrate, short-chain fatty acids, mucin degradation, ursodeoxycholic acid, bile acids, amino acids, polyunsaturated fatty acids, monounsaturated fatty acids, acetate, 16S rRNA gene, chemoprevention
- MeSH terms
- Adult, Aged, Aged, 80 and over, Carcinoma in Situ, Feces, Female, Health, Humans, Male, Middle Aged, Colorectal Neoplasms, Case-Control Studies, Metabolome, Microbiota
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.